Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa

Fig. 3

Example of participant intakes reported on Wisepill online dashboard. Example online dashboard display of device openings for a single participant during the three-week study period. The first day of the next medication week is shown with a dotted line. Medication dosing was self-administered. Blue diamonds indicate extra Wisepill device openings for weekly pill count or reloading medications. Red circles indicate a missed expected Wisepill device opening. *Nevirapine (NVP): 200 mg BID; Aluvia: Lopinavir 200 mg – 50 mg Ritonavir BID

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us